Mark J. Adler MD - 15 May 2026 Form 4 Insider Report for Forian Inc. (FORA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
15 May 2026, 17:25:01 UTC
Prior SEC filing
28 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Max C. Wygod, Attorney-in-Fact

Key filing fact

Mark J. Adler MD filed Form 4 for Forian Inc. (FORA) on 15 May 2026.

Key facts

  • This page summarizes Mark J. Adler MD's Form 4 filing for Forian Inc. (FORA).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 15 May 2026, 17:25.

Change

  • Previous filing in this sequence was filed on 28 Mar 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001230587 Primary reporting owner

ADLER MARK J MD

Relationship
Director
Address
C/O FORIAN INC., 41 UNIVERSITY DRIVE, SUITE 400, NEWTOWN
Signature
/s/ Max C. Wygod, Attorney-in-Fact
Signature date
15 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FORA transaction

Common Stock

Disposition pursuant to a tender of shares in a change of control transaction

Transaction value
Shares
-37,583
Change %
-100%
Price
Shares after
0
Date
15 May 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

FORA transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares
+15,000
Change %
Price
Shares after
0
Date
15 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,000
Exercise price
$2.06
Footnotes
F2, F3
FORA transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares
+15,000
Change %
Price
Shares after
0
Date
15 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,000
Exercise price
$3.20
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Mark J. Adler MD is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 3 footnotes

Footnote F1

Pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement"), dated April 2, 2026, by and between Forian Inc., a Maryland corporation (the "Issuer"), 2025 Acquisition Company, LLC, a Delaware limited liability company ("Parent"), and Bravo Merger Sub, Inc., a Maryland corporation and wholly owned subsidiary of Parent ("Merger Sub"), on May 15, 2026, Parent and Merger Sub completed a tender offer for the shares of the Issuer's common stock (the "Shares"). In exchange for each Share, tendering shareholders received $2.17 per Share (the "Offer Price"), payable in cash, without interest and subject to any applicable withholding taxes.

Footnote F2

On May 15, 2026, pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each vested stock option that had an exercise price per Share that was less than the Offer Price and that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive an amount in cash (without interest and subject to deduction for any required withholding taxes), equal to the product of: (i) the total number of Shares subject to such option, multiplied by (ii) the excess, if any, of (A) the Offer Price over (B) the exercise price payable per Share under such option.

Footnote F3

At the Effective Time, each stock option that was either (i) unvested or (ii) that had a per share exercise price per Share that was equal to or more than the Offer Price that was then outstanding and unexercised as of immediately prior to the Effective Time was cancelled without any consideration payable therefor.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .